CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: fosinopril
Accession: CHEBI:5163
browse the term
Definition: A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite.
Synonyms: exact_synonym: (4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline
related_synonym: (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; (2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid; (S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid; Formula=C30H46NO7P; InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1; InChIKey=BIDNLKIUORFRQP-FKDWWROVSA-N; SMILES=[H][C@]1(C[C@H](N(C1)C(=O)CP(=O)(CCCCc1ccccc1)OC(OC(=O)CC)C(C)C)C(O)=O)C1CCCCC1
alt_id: CHEBI:159901; CHEBI:288733
xref: Beilstein:8176492; CAS:98048-97-6; DrugBank:DB00492; KEGG:C07016; KEGG:D07992; LINCS:LSM-6485
xref_mesh: MESH:D017328
xref: PMID:11937741; PMID:18209565; PMID:22729889; PMID:8285178; PMID:9195116; Patent:CN101367839; Patent:EP2264039; Patent:US2010297711; Patent:US4337201
cyclic_relationship: is_conjugate_acid_of CHEBI:59125
G
Abcc1
ATP binding cassette subfamily C member 1
decreases response to substance
ISO
ABCC1 protein results in decreased susceptibility to Fosinopril
CTD
PMID:22095822
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
decreases response to substance increases export multiple interactions
ISO
ABCC2 protein results in decreased susceptibility to Fosinopril ABCC2 protein results in increased export of Fosinopril desloratadine inhibits the reaction [ABCC2 protein results in increased export of Fosinopril]; Loratadine inhibits the reaction [ABCC2 protein results in increased export of Fosinopril]; Methotrexate inhibits the reaction [ABCC2 protein results in increased export of Fosinopril] ABCC2 protein affects the reaction [Fosinopril affects the export of Methotrexate]
CTD
PMID:22095822
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Adipor2
adiponectin receptor 2
increases expression
EXP
fosinopril increases expression of adipor2 mRNA in rat liver
RGD
PMID:19076162
RGD:2307264
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Afp
alpha-fetoprotein
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]
CTD
PMID:29859236
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agt
angiotensinogen
decreases expression
EXP
Fosinopril results in decreased expression of AGT protein
CTD
PMID:12411096
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Bmpr2
bone morphogenetic protein receptor type 2
multiple interactions
EXP
Fosinopril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BMPR2 mRNA]
CTD
PMID:17803470
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
G
Ccnd1
cyclin D1
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]
CTD
PMID:29859236
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein]
CTD
PMID:29859236
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Kl
Klotho
increases expression
EXP
Fosinopril results in increased expression of KL mRNA; Fosinopril results in increased expression of KL protein
CTD
PMID:21051829
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of MMP2 protein]
CTD
PMID:29859236
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases expression multiple interactions
EXP
Fosinopril results in decreased expression of MMP9 mRNA; Fosinopril results in decreased expression of MMP9 protein [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 mRNA; [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 protein
CTD
PMID:21051829
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in decreased expression of NFKB1 protein]
CTD
PMID:29859236
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos3
nitric oxide synthase 3
affects expression
EXP
Fosinopril affects the expression of NOS3 mRNA; Fosinopril affects the expression of NOS3 protein
CTD
PMID:18209565
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Pde1a
phosphodiesterase 1A
affects expression
EXP
Fosinopril affects the expression of PDE1A mRNA; Fosinopril affects the expression of PDE1A protein
CTD
PMID:18209565
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pde1c
phosphodiesterase 1C
affects expression
EXP
Fosinopril affects the expression of PDE1C mRNA; Fosinopril affects the expression of PDE1C protein
CTD
PMID:18209565
NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:85,300,858...85,863,219
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of RELA protein]
CTD
PMID:29859236
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Serpine1
serpin family E member 1
decreases expression multiple interactions
EXP
Fosinopril results in decreased expression of SERPINE1 mRNA; Fosinopril results in decreased expression of SERPINE1 protein [Valsartan co-treated with Fosinopril] results in decreased expression of SERPINE1 mRNA; [Valsartan co-treated with Fosinopril] results in decreased expression of SERPINE1 protein
CTD
PMID:21051829
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc15a1
solute carrier family 15 member 1
multiple interactions
ISO
Fosinopril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine]
CTD
PMID:18713951
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Slc15a2
solute carrier family 15 member 2
multiple interactions
EXP
Fosinopril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine]
CTD
PMID:18713951
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of TGFB1 protein]
CTD
PMID:29859236
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
decreases expression multiple interactions
EXP
Fosinopril results in decreased expression of TIMP1 mRNA; Fosinopril results in decreased expression of TIMP1 protein [Valsartan co-treated with Fosinopril] results in decreased expression of TIMP1 mRNA; [Valsartan co-treated with Fosinopril] results in decreased expression of TIMP1 protein
CTD
PMID:21051829
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of TNF protein]
CTD
PMID:29859236
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of VEGFA protein]
CTD
PMID:29859236
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all